Analyst Price Targets — ATXS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 15, 2025 10:49 am | — | Wedbush | $13.00 | $11.61 | TheFly | Astria Therapeutics downgraded to Neutral from Outperform at Wedbush |
| October 14, 2025 5:05 pm | — | Jefferies | $13.00 | $11.61 | TheFly | Astria Therapeutics downgraded to Hold from Buy at Jefferies |
| October 1, 2025 1:19 pm | — | Evercore ISI | $26.00 | $7.52 | TheFly | Astria Therapeutics price target raised to $26 from $25 at Evercore ISI |
| May 21, 2024 7:50 am | Hartaj Singh | Oppenheimer | $25.00 | $9.59 | TheFly | Astria Therapeutics price target lowered to $25 from $29 at Oppenheimer |
| March 26, 2024 9:28 am | Hartaj Singh | Oppenheimer | $29.00 | $14.12 | StreetInsider | Astria Therapeutics (ATXS) PT Raised to $29 at Oppenheimer following positive Proof-of-Concept |
| December 19, 2022 6:14 am | — | H.C. Wainwright | $20.00 | $11.81 | Benzinga | HC Wainwright & Co. Maintains Buy on Astria Therapeutics, Raises Price Target to $20 |
Latest News for ATXS
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq: ATXS) today announced that at the special meeting of Astria's stockholders held on January 21, 2026, Astria's stockholders voted to approve the acquisition of Astria by BioCryst Pharmaceuticals, Inc. (the “Merger”). The parties expect the Merger to close on or about January 23, 2026, subject to the satisfaction of customary closing conditions. About Astria…
Swedish Orphan Biovitrum (OTCMKTS:BIOVF - Get Free Report) and Astria Therapeutics (NASDAQ: ATXS - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations. Valuation and Earnings This table compares Swedish
Astria Therapeutics, Inc. (NASDAQ: ATXS - Get Free Report) shares passed below its fifty day moving average during trading on Thursday. The stock has a fifty day moving average of $12.77 and traded as low as $12.45. Astria Therapeutics shares last traded at $12.81, with a volume of 1,076,980 shares traded. Analyst Upgrades and Downgrades
NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ATXS.
U.S. House Trading
No House trades found for ATXS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.